Literature DB >> 36006469

The phospho-landscape of the survival of motoneuron protein (SMN) protein: relevance for spinal muscular atrophy (SMA).

Nora Tula Detering1,2, Tobias Schüning1,2, Niko Hensel3,2, Peter Claus4,5.   

Abstract

Spinal muscular atrophy (SMA) is caused by low levels of the survival of motoneuron (SMN) Protein leading to preferential degeneration of lower motoneurons in the ventral horn of the spinal cord and brain stem. However, the SMN protein is ubiquitously expressed and there is growing evidence of a multisystem phenotype in SMA. Since a loss of SMN function is critical, it is important to decipher the regulatory mechanisms of SMN function starting on the level of the SMN protein itself. Posttranslational modifications (PTMs) of proteins regulate multiple functions and processes, including activity, cellular trafficking, and stability. Several PTM sites have been identified within the SMN sequence. Here, we map the identified SMN PTMs highlighting phosphorylation as a key regulator affecting localization, stability and functions of SMN. Furthermore, we propose SMN phosphorylation as a crucial factor for intracellular interaction and cellular distribution of SMN. We outline the relevance of phosphorylation of the spinal muscular atrophy (SMA) gene product SMN with regard to basic housekeeping functions of SMN impaired in this neurodegenerative disease. Finally, we compare SMA patient mutations with putative and verified phosphorylation sites. Thus, we emphasize the importance of phosphorylation as a cellular modulator in a clinical perspective as a potential additional target for combinatorial SMA treatment strategies.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Phosphorylation; Posttranslational modification (PTM); Spinal muscular atrophy (sMA); Survival of motoneuron (SMN) protein

Mesh:

Substances:

Year:  2022        PMID: 36006469     DOI: 10.1007/s00018-022-04522-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.207


  184 in total

Review 1.  Spinal muscular atrophy: going beyond the motor neuron.

Authors:  Gillian Hamilton; Thomas H Gillingwater
Journal:  Trends Mol Med       Date:  2012-12-08       Impact factor: 11.951

2.  Deletion of murine Smn exon 7 directed to liver leads to severe defect of liver development associated with iron overload.

Authors:  Jérémie M Vitte; Bénédicte Davoult; Natacha Roblot; Michèle Mayer; Vandana Joshi; Sabrina Courageot; François Tronche; Jacqueline Vadrot; Marie Helene Moreau; François Kemeny; Judith Melki
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

3.  Renal pathology in a mouse model of severe Spinal Muscular Atrophy is associated with downregulation of Glial Cell-Line Derived Neurotrophic Factor (GDNF).

Authors:  Hazel Allardyce; Daniela Kuhn; Elena Hernandez-Gerez; Niko Hensel; Yu-Ting Huang; Kiterie Faller; Thomas H Gillingwater; Fabio Quondamatteo; Peter Claus; Simon H Parson
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

4.  Abnormal fatty acid metabolism in childhood spinal muscular atrophy.

Authors:  T O Crawford; J T Sladky; O Hurko; A Besner-Johnston; R I Kelley
Journal:  Ann Neurol       Date:  1999-03       Impact factor: 10.422

5.  The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation.

Authors:  Rebeca Martínez-Hernández; Carolina Soler-Botija; Eva Also; Laura Alias; Lidia Caselles; Ignasi Gich; Sara Bernal; Eduardo F Tizzano
Journal:  J Neuropathol Exp Neurol       Date:  2009-05       Impact factor: 3.685

6.  Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.

Authors:  Yimin Hua; Kentaro Sahashi; Frank Rigo; Gene Hung; Guy Horev; C Frank Bennett; Adrian R Krainer
Journal:  Nature       Date:  2011-10-05       Impact factor: 49.962

Review 7.  Cardiac pathology in spinal muscular atrophy: a systematic review.

Authors:  C A Wijngaarde; A C Blank; M Stam; R I Wadman; L H van den Berg; W L van der Pol
Journal:  Orphanet J Rare Dis       Date:  2017-04-11       Impact factor: 4.123

8.  Impaired kidney structure and function in spinal muscular atrophy.

Authors:  Flávia C Nery; Jennifer J Siranosian; Ivy Rosales; Marc-Olivier Deguise; Amita Sharma; Abdurrahman W Muhtaseb; Pann Nwe; Alec J Johnstone; Ren Zhang; Maryam Fatouraei; Natassja Huemer; Christiano R R Alves; Rashmi Kothary; Kathryn J Swoboda
Journal:  Neurol Genet       Date:  2019-08-12

9.  Abnormal fatty acid metabolism is a core component of spinal muscular atrophy.

Authors:  Marc-Olivier Deguise; Giovanni Baranello; Chiara Mastella; Ariane Beauvais; Jean Michaud; Alessandro Leone; Ramona De Amicis; Alberto Battezzati; Christopher Dunham; Kathryn Selby; Jodi Warman Chardon; Hugh J McMillan; Yu-Ting Huang; Natalie L Courtney; Alannah J Mole; Sabrina Kubinski; Peter Claus; Lyndsay M Murray; Melissa Bowerman; Thomas H Gillingwater; Simona Bertoli; Simon H Parson; Rashmi Kothary
Journal:  Ann Clin Transl Neurol       Date:  2019-07-26       Impact factor: 4.511

10.  Survival Motor Neuron (SMN) protein is required for normal mouse liver development.

Authors:  Eva Szunyogova; Haiyan Zhou; Gillian K Maxwell; Rachael A Powis; Francesco Muntoni; Thomas H Gillingwater; Simon H Parson
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.